{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:11:54Z","timestamp":1792721514531,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-04891-8","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T13:02:33Z","timestamp":1677934953000},"page":"2265-2271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study"],"prefix":"10.1007","volume":"182","author":[{"given":"Xinyi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-2595","authenticated-orcid":false,"given":"Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"4891_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ, Group ESCSD","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ, Group ESCSD (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"4891_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"4891_CR3","doi-asserted-by":"publisher","unstructured":"Banavalikar B, Shenthar J, Padmanabhan D, Valappil SP, Singha SI, Kottayan A, Ghadei M, Ali M (2019) Clinical and electrophysiological correlates of incessant ivabradine-sensitive atrial tachycardia. Circ Arrhythm Electrophysiol 12:e007387. https:\/\/doi.org\/10.1161\/CIRCEP.119.007387","DOI":"10.1161\/CIRCEP.119.007387"},{"key":"4891_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fped.2020.00313","volume":"8","author":"H Michel","year":"2020","unstructured":"Michel H, Heissenhuber F, Wellmann S, Melter M, Gerling S (2020) Ectopic atrial tachycardia in a 12-month-old girl treated with ivabradine and beta-blocker, a case report. Front Pediatr 8:313. https:\/\/doi.org\/10.3389\/fped.2020.00313","journal-title":"Front Pediatr"},{"key":"4891_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/apc.apc_37_21","volume":"14","author":"B Karmegaraj","year":"2021","unstructured":"Karmegaraj B, Balaji S, Raju PN, Subramanian P, Subramanian R, Ibrahim S, Razeen M, Krishnakumar R (2021) Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: potential new indication for early initiation of enteral ivabradine. Ann Pediatr Cardiol 14:422\u2013427. https:\/\/doi.org\/10.4103\/apc.apc_37_21","journal-title":"Ann Pediatr Cardiol"},{"key":"4891_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.hrcr.2022.03.011","volume":"8","author":"G Hackett","year":"2022","unstructured":"Hackett G, Lin TK, Imundo JR (2022) Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease. Heart Rhythm Case Rep 8:415\u2013419. https:\/\/doi.org\/10.1016\/j.hrcr.2022.03.011","journal-title":"HeartRhythm Case Rep"},{"key":"4891_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCEP.113.001423","volume":"7","author":"KT Kang","year":"2014","unstructured":"Kang KT, Etheridge SP, Kantoch MJ, Tisma-Dupanovic S, Bradley DJ, Balaji S, Hamilton RM, Singh AK, Cannon BC, Schaffer MS, Potts JE, Sanatani S (2014) Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol 7:664\u2013670. https:\/\/doi.org\/10.1161\/CIRCEP.113.001423","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"4891_CR8","doi-asserted-by":"publisher","unstructured":"Teh AW, Kistler PM, Kalman JM (2009) Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia. J Cardiovasc Electrophysiol 20:706\u2013709; quiz 705. https:\/\/doi.org\/10.1111\/j.1540-8167.2009.01456.x","DOI":"10.1111\/j.1540-8167.2009.01456.x"},{"key":"4891_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.jacep.2021.05.005","volume":"7","author":"PM Kistler","year":"2021","unstructured":"Kistler PM, Chieng D, Tonchev IR, Sugumar H, Voskoboinik A, Schwartz LA, McLellan AJ, Prabhu S, Ling LH, Al-Kaisey A, Parameswaran R, Anderson RD, Lee G, Kalman JM (2021) P-wave morphology in focal atrial tachycardia: an updated algorithm to predict site of origin. JACC Clin Electrophysiol 7:1547\u20131556. https:\/\/doi.org\/10.1016\/j.jacep.2021.05.005","journal-title":"JACC Clin Electrophysiol"},{"key":"4891_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.jacc.2009.02.014","volume":"53","author":"C Medi","year":"2009","unstructured":"Medi C, Kalman JM, Haqqani H, Vohra JK, Morton JB, Sparks PB, Kistler PM (2009) Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol 53:1791\u20131797. https:\/\/doi.org\/10.1016\/j.jacc.2009.02.014","journal-title":"J Am Coll Cardiol"},{"key":"4891_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jacep.2021.01.020","volume":"7","author":"B Arvind","year":"2021","unstructured":"Arvind B, Kothari SS, Juneja R, Saxena A, Ramakrishnan S, Gupta SK, Chowdhury UK, Devagourou V, Talwar S, Hote MP, Rajashekar P, Sahu MK, Singh SP (2021) Ivabradine versus amiodarone in the management of postoperative junctional ectopic tachycardia: a randomized, open-label, noninferiority study. JACC Clin Electrophysiol 7:1052\u20131060. https:\/\/doi.org\/10.1016\/j.jacep.2021.01.020","journal-title":"JACC Clin Electrophysiol"},{"key":"4891_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10557-020-07124-4","volume":"35","author":"C Chen","year":"2021","unstructured":"Chen C, Kaur G, Mehta PK, Morrone D, Godoy LC, Bangalore S, Sidhu MS (2021) Ivabradine in cardiovascular disease management revisited: a review. Cardiovasc Drugs Ther 35:1045\u20131056. https:\/\/doi.org\/10.1007\/s10557-020-07124-4","journal-title":"Cardiovasc Drugs Ther"},{"key":"4891_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.hrthm.2017.10.004","volume":"15","author":"ST Mathew","year":"2018","unstructured":"Mathew ST, Po SS, Thadani U (2018) Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: a pooled analysis of prospective studies. Heart Rhythm 15:240\u2013247. https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.004","journal-title":"Heart Rhythm"},{"key":"4891_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1540-8167.2010.01860.x","volume":"22","author":"S Bohora","year":"2011","unstructured":"Bohora S, Lokhandwala Y, Parekh P, Vasavda A (2011) Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. J Cardiovasc Electrophysiol 22:340\u2013342. https:\/\/doi.org\/10.1111\/j.1540-8167.2010.01860.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"4891_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.hrcr.2019.03.007","volume":"5","author":"CM Janson","year":"2019","unstructured":"Janson CM, Tan RB, Iyer VR, Vogel RL, Vetter VL, Shah MJ (2019) Ivabradine for treatment of tachyarrhythmias in children and young adults. Heart Rhythm Case Rep 5:333\u2013337. https:\/\/doi.org\/10.1016\/j.hrcr.2019.03.007","journal-title":"HeartRhythm Case Rep"},{"key":"4891_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C, Calkins H, Corrado D, Deftereos SG, Diller GP, Gomez-Doblas JJ, Gorenek B, Grace A, Ho SY, Kaski JC, Kuck KH, Lambiase PD, Sacher F, Sarquella-Brugada G, Suwalski P, Zaza A, Group ESCSD","year":"2020","unstructured":"Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C, Calkins H, Corrado D, Deftereos SG, Diller GP, Gomez-Doblas JJ, Gorenek B, Grace A, Ho SY, Kaski JC, Kuck KH, Lambiase PD, Sacher F, Sarquella-Brugada G, Suwalski P, Zaza A, Group ESCSD (2020) 2019 ESC Guidelines for the management of patients with supraventricular tachycardia the Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 41:655\u2013720. https:\/\/doi.org\/10.1093\/eurheartj\/ehz467","journal-title":"Eur Heart J"},{"key":"4891_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S1047951120001195","volume":"30","author":"MI Cohen","year":"2020","unstructured":"Cohen MI, Cohen JA, Shope C, Stollar L, Collazo L (2020) Ivabradine as a stabilising anti-arrhythmic agent for multifocal atrial tachycardia. Cardiol Young 30:899\u2013902. https:\/\/doi.org\/10.1017\/S1047951120001195","journal-title":"Cardiol Young"},{"key":"4891_CR18","doi-asserted-by":"publisher","unstructured":"Leventopoulos G, Perperis A, Karelas D, Almpanis G (2021) You cannot ablate the Lernaean Hydra: SCN5A mutation in a patient with multifocal ectopic Purkinje-related premature contractions syndrome treated with Flecainide and an implant of a subcutaneous defibrillator-a case report. Eur Heart J Case Rep 5: ytab158. https:\/\/doi.org\/10.1093\/ehjcr\/ytab158","DOI":"10.1093\/ehjcr\/ytab158"},{"key":"4891_CR19","doi-asserted-by":"publisher","unstructured":"Younis NK, Abi-Saleh B, Al Amin F, El Sedawi O, Tayeh C, Bitar F, Arabi M (2021) Ivabradine: a potential therapeutic for children with refractory SVT. Front Cardiovasc Med 8: 660855. https:\/\/doi.org\/10.3389\/fcvm.2021.660855","DOI":"10.3389\/fcvm.2021.660855"},{"key":"4891_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","volume":"70","author":"D Bonnet","year":"2017","unstructured":"Bonnet D, Berger F, Jokinen E, Kantor PF, Daubeney PEF (2017) Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure. J Am Coll Cardiol 70:1262\u20131272. https:\/\/doi.org\/10.1016\/j.jacc.2017.07.725","journal-title":"J Am Coll Cardiol"},{"key":"4891_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","volume":"377","author":"S Fleming","year":"2011","unstructured":"Fleming S, Thompson M, Stevens R, Heneghan C, Pluddemann A, Maconochie I, Tarassenko L, Mant D (2011) Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet 377:1011\u20131018. https:\/\/doi.org\/10.1016\/S0140-6736(10)62226-X","journal-title":"Lancet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-04891-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T10:38:19Z","timestamp":1683801499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-04891-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["4891"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-04891-8","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of Shanghai Children\u2019s Medical Center (SCMCIRB-K2021058-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"Before ivabradine therapy was initiated, the off-label use and potential side effects were explained in detail to the parents, and informed written consent was obtained from the guardians of each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare that they have no conflicts of interest related.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}